Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)

Record ID 32011000873
Authors' objectives:

Tumor necrosis factor (TNF) receptor–associated periodic syndrome (TRAPS) is one of a recently defined class of autoinflammatory disorders called hereditary recurrent fevers. These disorders generally feature episodes of acute inflammation, fever, and pain. TRAPS was originally called familial Hibernian fever (FHF) to reflect the ancestry of the index patient, but has since been described in patients of various ethnicities. TRAPS is inherited in an autosomal dominant pattern and is caused by variants in the TNF receptor superfamily 1A (TNFRSF1A) gene. TNFRSF1A encodes a protein important to the inflammatory response. The pathogenesis of TRAPS is not entirely understood, but it has been found that variants in different locations of the TNFRSF1A gene lead to disruptions of the normal inflammatory response. Differential diagnosis of TRAPS is challenging as symptoms vary broadly and overlap with those of other disorders, and there is no functional test for the disorder. The key risk engendered by the long-term autoinflammation associated with TRAPS is amyloidosis, the potentially fatal accumulation of amyloid protein in organs and tissues. TRAPS responds well to corticosteroids, but as long-term use of these is undesirable, other treatments are being investigated, including the soluble p75 TNFR-Fc fusion protein etanercept.

Project Status: Completed
Year Published: 2011
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Familial Mediterranean Fever
  • Receptors, Tumor Necrosis Factor
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2011 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.